This year the sessions are grouped in 3 different themes:
1. Chemical Biology
2. Drug Discovery Projects
3. Technologies

In addition, the programme contains four open sessions : First Time Disclosures (I & II), Emerging Topics and Late Breaking News. For these sessions, the talks will be selected from the submitted abstracts.

For most of the below topics, a slot in the programme will be available for an oral communication selected out of the submitted abstracts.

Chemical Biology

• Carbohydrate Recognition and Drug Design
  Session Chair: Dr Alexander Titz, Helmholtz Institute for Pharmaceutical Sciences, Germany
  
  
• Chemical Approaches to Stem Cell Differentiation (ICBS Session)
  Session Chair: Prof. Colin Pouton, Monash University, Australia
  
  
• Chemical Probes for Target Discovery and Validation
  Session Chair: Prof. Gyorgy Keseru, Hungarian Academy of Sciences, Hungary
  
  
• Molecular Imaging Tools for Chemical Biology
  Session Chair: Dr Valle Palomo, CIB, Spain
  
  
• Photochemistry in Drug Discovery: Photopharmacology, Phototoxicity and Synthesis (ACSMEDI Session)
  Session Chairs: Mr Timothy Henderson, MSD, United States & Dr Amjad Ali, MSD, United States
  
  
• Small Molecules Targeting RNA Function and Processing
  Session Chair: Dr Maria Duca, University of Côte d'Azur, France
  
  
• Target Deconvolution Strategies in Drug Discovery
  Session Chair: Prof. Paul Brennan, University of Oxford, United Kingdom
  

Drug Discovery Projects

• Addressing Neglected and Emerging Viral Diseases with Small Molecules (AFMC Session)
  Session Chair: Prof. Esin Aki-Yalçin, Ankara University, Turkey
  
  
• Breathing Life into Inhaled Drug Discovery: Challenges and Breakthroughs to the Clinic (ACSMEDI Session)
  Session Chair: Dr Nicole Goodwin, GSK, United States
  
  
• Chemical Tools and Drug Discovery for Neuroinflammation (EuChemS Session)
  Session Chair: Dr Sonsoles Martin-Santamaria, Biological Research Center, Spain
  
  
• New Strategies and Agents for Targeting Gram-Negative Pathogens
  Session Chair: Dr Vicky Steadman, Selcia, United Kingdom
  
  
• Next Generation Drugs for Heart Failure
  Session Chair: Dr Alleyn Plowright, Wren Therapeutics, United Kingdom
  
  
• Recent Advances in Anticancer Drug Discovery
  Session Chair: Prof. Roberto di Santo, Sapienza University of Rome, Italy
  
  
• Targeting Fibrotic Diseases with Small Molecules
  Session Chair: Dr Christian Kuttruff, Boehringer Ingelheim, Germany
  
  
• Tissue and Cell Specific Drug Delivery (EUFEPS Session)
  Session Chair: Prof. Sébastien Papot, University of Poitiers, France
  
  

Technologies

• Application of Artificial Intelligence in Drug Discovery Projects
  Session Chair: Dr Christopher Swain, Cambridge MedChem Consulting, United Kingdom
  
  
• Biocatalysis & Late Stage Functionalisation
  Session Chair: Dr Radka Snajdrova, Novartis, Switzerland
  
  
• Cryo-EM as an Emerging Tool for Small-Molecule Drug Discovery
  Session Chair: Dr Jean-Paul Renaud, Urania Therapeutics, France
  
  
• Expanding Chemical Space through AI - Linking Synthesis Prediction and Automation
  Session Chair: Dr Ola Engkvist, AstraZeneca, Sweden
  
  
• Innovative Synthesis for Medicinal Chemistry
  Session Chair: Prof. Cristina Nevado, University of Zurich, Switzerland
  
  
• Novel Strategies and Methods for Drug Discovery and Development (CPA Session)
  Session Chair: Prof. Ke Ding, Jinan University, China
  
  
• Prodrug Strategies in Drug Design and Discovery
  Session Chairs: Prof. Bernd Clement, University of Kiel, Germany & Prof. Jarkko Rautio, University of Eastern Finland, Finland
  
  

Open Sessions (selected from submitted abstracts)

• First Time Disclosures (I & II)
  Session Chairs to be announced
  
  
• Emerging Topics
  Session Chair to be announced
  
  
• Late Breaking News
  Session Chair to be announced